MARKET

CVET

CVET

Covetrus Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

20.96
-0.50
-2.33%
Opening 11:51 09/21 EDT
OPEN
20.81
PREV CLOSE
21.46
HIGH
21.06
LOW
20.30
VOLUME
175.05K
TURNOVER
--
52 WEEK HIGH
25.21
52 WEEK LOW
4.045
MARKET CAP
2.36B
P/E (TTM)
-2.4025
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Arrowhead Pharmaceuticals, Myomo leads healthcare gainers, Novus Therapeutics, Jounce Therapeutics among major losers
Gainers: Arrowhead Pharmaceuticals (ARWR) +46%, Myomo (MYO) +38%, AxoGen (AXGN) +15%, Covetrus (CVET) +14%, Inovio Pharmaceuticals (INO) +13%.Losers: Novus Therapeutics (NVUS) -13%, Jounce Therapeutics (JNCE) -10%, Syneos Health (SYNH) -7%, Verastem (VSTM) -5%, Evogene (EVGN) -5%.
Seekingalpha · 5d ago
Can You Imagine How Covetrus' (NASDAQ:CVET) Shareholders Feel About The 70% Share Price Increase?
Simply Wall St. · 09/01 15:11
Covetrus Appoints Jamey Seely General Counsel
Business Wire · 09/01 13:30
Covetrus Pharmacy Team Manufactures and Donates Hand Sanitizer for Local Communities Impacted by COVID-19 Pandemic
Covetrus donated 6,000 bottles of hand sanitizer to help protect Phoenix communities and Arizona medical personnel from coronavirus.
Business Wire · 08/25 13:30
CVET vs. SOGO: Which Stock Is the Better Value Option?
Zacks · 08/18 16:40
Surging Earnings Estimates Signal Upside for Covetrus (CVET) Stock
Zacks · 08/14 17:20
Covetrus (CVET) Is Up 3.56% in One Week: What You Should Know
Zacks · 08/14 17:00
Covetrus shares are trading higher after the company reported better-than-expected Q2 sales results. UPDATE: Shares have since reversed.
Benzinga · 08/12 17:01
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CVET stock price target is 20.00 with a high estimate of 26.00 and a low estimate of 14.00.
EPS
Institutional Holdings
Institutions: 331
Institutional Holdings: 111.67M
% Owned: 98.98%
Shares Outstanding: 112.83M
TypeInstitutionsShares
Increased
65
7.49M
New
81
3.57M
Decreased
77
13.71M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-2.19%
Healthcare Equipment & Supplies
-2.16%
Key Executives
Chairman/Independent Director
Philip Laskawy
President/Chief Executive Officer/Director
Benjamin Wolin
Chief Financial Officer
Matthew Foulston
Corporate Executive
Matthew Malenfant
Executive Vice President
Michael Ellis
Executive Vice President
David Hinton
Executive Vice President
Timothy Ludlow
Executive Vice President
Anthony Providenti
Executive Vice President
Georgina Wraight
Senior Vice President/General Counsel/Secretary
Erin Brennan
Chief Accounting Officer/Vice President/Controller
Laura Phillips
Chief Administrative Officer
Dustin Finer
Chief Information Officer
Steve Palmucci
Other
Arman Samani
Director
Steven Paladino
Director
Sandra Peterson
Independent Director
Deborah Ellinger
Independent Director
Sandra Helton
Independent Director
Mark Manoff
Independent Director
Edward McNamara
Independent Director
Ravi Sachdev
  • Dividends
  • Splits
  • Insider Activity
No Data

Analyst Price Target

The average CVET stock price target is 20.00 with a high estimate of 26.00 and a low estimate of 14.00.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About CVET
Covetrus, Inc. is a global animal-health technology and services company. The Company provides service and technology platform to animal veterinary markets. The Company operates in three segments: North America, Europe and APCA & Emerging Markets. The Company combines practice management software and supply chain distribution businesses with a technology-enabled prescription management platform and related pharmacy services.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Covetrus Inc stock information, including NASDAQ:CVET real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CVET stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CVET stock methods without spending real money on the virtual paper trading platform.